Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Marjolein de Bruin‐Weller
ResearcherPublications, citations & collaboration network
Marjolein de Bruin‐Weller is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 364 works, 14,269 citations, an h-index of 56 and an i10-index of 173.
364
Works
14,269
Citations
56
h-index
173
i10-index
How has Marjolein de Bruin‐Weller's publication output changed over time?
ScholarIQpublication output · 2004–2021
Output grew200% over the shown period — from 1 works in 2004 to 3 in 2021.
1
1
1
2
1
2
1
3
20042005201620172018201920202021
What are the most-cited papers on Marjolein de Bruin‐Weller?
ScholarIQmost cited works
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham, Jennifer Clay Cather, Jamie Weisman, David M. Pariser, Eric L. Simpson, Kim Papp, Hyuck-Ki Hong, Diana Rubel, Peter Foley, Errol P. Prens, C.E.M. Griffiths, Takafumi Etoh, Pedro Herranz, Ramón M. Pujol, Jacek C. Szepietowski, Karel Ettler, Lajos Kemény, Xiaoping Zhu, Bolanle Akinlade, Thomas Hultsch, Vera Mastey, Abhijit Gadkari, Laurent Eckert, Nikhil Amin, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Brad Shumel
The Lancet. 20171,258 CitationsOPEN ACCESS
Epidemiology of atopic dermatitis in adults: Results from an international survey
S. Barbarot, S. Auziere, A. Gadkari, Giampiero Girolomoni, L. Puig, Eric L. Simpson, David J. Margolis, Marjolein de Bruin‐Weller, Laurent Eckert
Allergy. 2018881 CitationsOPEN ACCESS
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson, Antonio Costanzo, Marjolein de Bruin‐Weller, S. Barbarot, Vimal H. Prajapati, Peter Lio, Xiaofei Hu, Tianshuang Wu, John Liu, Barry Ladizinski, Alvina D. Chu, Kilian Eyerich
JAMA Dermatology. 2021494 CitationsOPEN ACCESS
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith, Kristian Reich, Michael J. Cork, Allen Radin, Q. Zhang, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Thomas Hultsch, Z. Chen, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel
British Journal of Dermatology. 2017476 CitationsOPEN ACCESS
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, C. Paul, Jacob P. Thyssen, Marjolein de Bruin‐Weller, Christian Vestergaard, Julien Sénéschal, Thomas Werfel, Michael J. Cork, B Kunz, Regina Fölster‐Holst, Magdalena Trzeciak, Ulf Darsow, Zsuzsanna Szalai, Mette Deleuran, Laura von Kobyletzki, S. Barbarot, Annice Heratizadeh, Uwe Gieler, DirkJan Hijnen, Stephan Weidinger, L. De Raeve, Åke Svensson, Dagmar Simon, J.‐F. Stalder, Johannes Ring, for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force
Journal of the European Academy of Dermatology and Venereology. 2020472 CitationsOPEN ACCESS
Related on ScholarIQ
Utrecht University
Institution
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Paper
Epidemiology of atopic dermatitis in adults: Results from an international survey
Paper
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
Paper
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
Paper
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Paper